Clinical Trial of the TQB2930 Injection in Patients With Advanced Cancers

Status Recruiting

Clinical Trial Summary

TQB2930 is an anti-HER2 (Human Epidermal Growth Factor Receptor 2) bispecific antibody that can simultaneously bind two epitopes of HER2, leading to a dual HER2 signal blockage. This is a phase I study to evaluate the safety, tolerability and effectiveness of TQB2930 injection in subjects with advanced malignancies.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05380882
Study type	Interventional
Source	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Contact	Ruihua Xu, Doctor
Phone	86-20-87343468
Email	ruihxu@163.com
Status	Recruiting
Phase	Phase 1
Start date	May 2022
Completion date	December 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01213238` - Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab	Phase 1
Recruiting	`NCT02160366` - Profile Related Evidence to Determine Individualized Cancer Therapy (PREDICT) Program in Advanced Cancer Patients
Completed	`NCT00379353` - The Effects of Thalidomide on Symptom Clusters	Phase 2
Completed	`NCT00903708` - LY2275796 in Advanced Cancer	Phase 1
Terminated	`NCT00499382` - Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET/CT Scans For Tumor Staging	N/A
Completed	`NCT02459964` - Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain	Phase 4
Completed	`NCT01430572` - Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients	Phase 1
Completed	`NCT02561234` - A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors	Phase 1/Phase 2
Active, not recruiting	`NCT01375114` - The Effects of Ginseng on Cancer-Related Fatigue	Phase 2
Completed	`NCT01201694` - Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L)	Phase 1
Completed	`NCT01454804` - Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors	Phase 1
Completed	`NCT02801045` - Art Therapy in Palliative Care: Study of Identification and Understanding of the Mechanisms of Change in the Patient	N/A
Completed	`NCT02873975` - A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency	Phase 2
Completed	`NCT01983969` - Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma	Phase 1/Phase 2
Completed	`NCT02272595` - Rational Therapeutics Based on Matched Tumor and Normal Tissue
Active, not recruiting	`NCT01999491` - A Phase 1 Dose-Escalation and Pharmacokinetic Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma	Phase 1
Recruiting	`NCT03375983` - Plasmodium Immunotherapy for Advanced Cancers	Phase 1/Phase 2
Completed	`NCT02571036` - A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies	Phase 1
Withdrawn	`NCT01608139` - Study of Curcumin, Vorinostat, and Sorafenib	Phase 1
Completed	`NCT01024166` - Patient-Reported Outcomes-Based Palliative and Hospice Care Practice: A Usability Study	N/A